Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Porcine Epidemic Diarrhoea Vaccines Market: By Type ; By Application and Geography
Porcine Epidemic Diarrhoea Vaccines Market: By Type ; By Application and Geography
Porcine Epidemic Diarrhoea Vaccines Market size was valued at US$ 1,819.3 million in 2023 and poised to grow at 7.1% CAGR from (2024-2030). PED is a viral disease of pigs characterized by serious diarrhoea, vomiting, and high mortality rates in piglets. As one of the key diseases with important economic ramifications for the swine sector, the development and use of vaccines are very important in controlling outbreaks and reducing losses. The frequent outbreaks of PED, particularly in large pork-producing regions, drive the demand for effective vaccines. The Chinese Ministry of Agriculture reports that China produces over 50% of the world's pork, highlighting the critical role of PED vaccines in maintaining industry stability. Also, growing awareness among swine producers about the benefits of vaccination is driving market demand.
However, the cost of vaccines may be prohibitive for small-scale swine producers, limiting market penetration in some regions. Also, variability in vaccine efficacy due to different PED virus strains can be a challenge in achieving widespread adoption. Whereas, the increasing swine production in emerging markets presents significant opportunities for vaccine manufacturers.
Study Period
2024-2030Base Year
2023CAGR
7.1%Largest Market
Asia PacificFastest Growing Market
North America
The market is shaped by various dynamics, including the demand for effective disease control measures, government regulations, and the competitive landscape. The ongoing efforts to develop more effective vaccines and improve distribution networks are key factors influencing market growth. Additionally, the economic importance of the swine industry ensures that PED vaccines remain a priority for producers and policymakers. According to the USDA, the U.S. swine industry is valued at over $22 billion annually, with PED outbreaks causing significant losses, underscoring the importance of vaccination.
Based on the region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America, particularly the U.S., is the leading market due to the large swine industry and frequent PED outbreaks. The U.S. Department of Agriculture (USDA) has reported multiple PED outbreaks, leading to increased demand for vaccines. Moreover, the Asia-Pacific region, especially China, has a large swine population and is highly susceptible to PED outbreaks, driving significant market growth. Europe has a well-established market for PED vaccines, supported by stringent animal health regulations and high awareness among swine producers.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 1,819.3 million |
|
Market CAGR |
7.1% |
|
By Type |
|
|
By Application |
|
|
By Region |
|
Download Free Sample Report
PED is a viral disease affecting pigs, causing severe diarrhoea and high mortality, especially in piglets.
The market is growing due to recurring PED outbreaks, economic losses in the swine industry, and government support for vaccination programs.
North America, particularly the U.S., leads the market due to its large swine industry and frequent PED outbreaks.
Major drivers include the economic impact of PED, increasing awareness of vaccination benefits, and government initiatives.
| 1.Executive Summary |
| 2.Global Porcine Epidemic Diarrhoea Vaccines Market Introduction |
| 2.1.Global Porcine Epidemic Diarrhoea Vaccines Market - Taxonomy |
| 2.2.Global Porcine Epidemic Diarrhoea Vaccines Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Application |
| 2.2.3.Region |
| 3.Global Porcine Epidemic Diarrhoea Vaccines Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Porcine Epidemic Diarrhoea Vaccines Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Porcine Epidemic Diarrhoea Vaccines Market By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Live Vaccines |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Killed Vaccines |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Porcine Epidemic Diarrhoea Vaccines Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Piglets |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Adults Pigs |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Porcine Epidemic Diarrhoea Vaccines Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Porcine Epidemic Diarrhoea Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Live Vaccines |
| 8.1.2.Killed Vaccines |
| 8.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Piglets |
| 8.2.2.Adults Pigs |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Porcine Epidemic Diarrhoea Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Live Vaccines |
| 9.1.2.Killed Vaccines |
| 9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Piglets |
| 9.2.2.Adults Pigs |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) Porcine Epidemic Diarrhoea Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Live Vaccines |
| 10.1.2.Killed Vaccines |
| 10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Piglets |
| 10.2.2.Adults Pigs |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Porcine Epidemic Diarrhoea Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Live Vaccines |
| 11.1.2.Killed Vaccines |
| 11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Piglets |
| 11.2.2.Adults Pigs |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Porcine Epidemic Diarrhoea Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Live Vaccines |
| 12.1.2.Killed Vaccines |
| 12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Piglets |
| 12.2.2.Adults Pigs |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Green Cross Veterinary Products |
| 13.2.2.Harrisvaccines |
| 13.2.3.Komipharm |
| 13.2.4.Nisseiken |
| 13.2.5.Qilu Animal Health |
| 13.2.6.Zoetis |
| 13.2.7.CAVAC |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.